86 related articles for article (PubMed ID: 22287761)
1. The mRNA expression of DAP3 in human breast cancer: correlation with clinicopathological parameters.
Wazir U; Jiang WG; Sharma AK; Mokbel K
Anticancer Res; 2012 Feb; 32(2):671-4. PubMed ID: 22287761
[TBL] [Abstract][Full Text] [Related]
2. The mRNA expression of DAP1 in human breast cancer: correlation with clinicopathological parameters.
Wazir U; Jiang WG; Sharma AK; Mokbel K
Cancer Genomics Proteomics; 2012; 9(4):199-201. PubMed ID: 22798505
[TBL] [Abstract][Full Text] [Related]
3. The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer.
Al Sarakbi W; Mokbel R; Salhab M; Jiang WG; Reed MJ; Mokbel K
Anticancer Res; 2006; 26(6C):4985-90. PubMed ID: 17214375
[TBL] [Abstract][Full Text] [Related]
4. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.
Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K
Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304
[TBL] [Abstract][Full Text] [Related]
5. Evidence of a tumour suppressive function of E2F1 gene in human breast cancer.
Worku D; Jouhra F; Jiang GW; Patani N; Newbold RF; Mokbel K
Anticancer Res; 2008; 28(4B):2135-9. PubMed ID: 18751386
[TBL] [Abstract][Full Text] [Related]
6. Survivin expression predicts early recurrence in early-stage breast cancer.
Yamashita S; Masuda Y; Kurizaki T; Haga Y; Murayama T; Ikei S; Kamei M; Takeno S; Kawahara K
Anticancer Res; 2007; 27(4C):2803-8. PubMed ID: 17695451
[TBL] [Abstract][Full Text] [Related]
7. The mRNA expression of inhibitors of DNA binding-1 and -2 is associated with advanced tumour stage and adverse clinical outcome in human breast cancer.
Wazir U; Jiang WG; Sharma AK; Newbold RF; Mokbel K
Anticancer Res; 2013 May; 33(5):2179-83. PubMed ID: 23645773
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a tumour suppressive function of APRG1 in breast cancer.
Leris AC; Roberts TR; Jiang WG; Newbold RF; Mokbel K
Breast Cancer Res Treat; 2005 Sep; 93(2):97-100. PubMed ID: 16187228
[TBL] [Abstract][Full Text] [Related]
9. Transforming acidic coiled-coil-containing protein 2 (TACC2) in human breast cancer, expression pattern and clinical/prognostic relevance.
Cheng S; Douglas-Jones A; Yang X; Mansel RE; Jiang WG
Cancer Genomics Proteomics; 2010; 7(2):67-73. PubMed ID: 20335520
[TBL] [Abstract][Full Text] [Related]
10. Guanine nucleotide binding protein β 1: a novel transduction protein with a possible role in human breast cancer.
Wazir U; Jiang WG; Sharma AK; Mokbel K
Cancer Genomics Proteomics; 2013; 10(2):69-73. PubMed ID: 23603342
[TBL] [Abstract][Full Text] [Related]
11. Osteopontin expression profiles predict pathological and clinical outcome in breast cancer.
Patani N; Jouhra F; Jiang W; Mokbel K
Anticancer Res; 2008; 28(6B):4105-10. PubMed ID: 19192668
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of 5-lipoxygenase-activating protein (5-LOXAP) has prognostic and survival significance in patients with breast cancer.
Jiang WG; Douglas-Jones AG; Mansel RE
Prostaglandins Leukot Essent Fatty Acids; 2006 Feb; 74(2):125-34. PubMed ID: 16364620
[TBL] [Abstract][Full Text] [Related]
13. Evidence for a tumour suppressive function of IGF1-binding proteins in human breast cancer.
Subramanian A; Sharma AK; Banerjee D; Jiang WG; Mokbel K
Anticancer Res; 2007; 27(5B):3513-8. PubMed ID: 17972510
[TBL] [Abstract][Full Text] [Related]
14. Evidence of an autocrine role for leptin and leptin receptor in human breast cancer.
Wazir U; Al Sarakbi W; Jiang WG; Mokbel K
Cancer Genomics Proteomics; 2012 Nov; 9(6):383-7. PubMed ID: 23162077
[TBL] [Abstract][Full Text] [Related]
15. mtDNA controls expression of the Death Associated Protein 3.
Jacques C; Chevrollier A; Loiseau D; Lagoutte L; Savagner F; Malthièry Y; Reynier P
Exp Cell Res; 2006 Apr; 312(6):737-45. PubMed ID: 16413536
[TBL] [Abstract][Full Text] [Related]
16. Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer.
Yang DC; Wang F; Elliott RL; Head JF
Anticancer Res; 2001; 21(1B):541-9. PubMed ID: 11299801
[TBL] [Abstract][Full Text] [Related]
17. Evidence of a tumour suppressor function for DLEC1 in human breast cancer.
Al Sarakbi W; Reefy S; Jiang WG; Roberts T; Newbold RF; Mokbel K
Anticancer Res; 2010 Apr; 30(4):1079-82. PubMed ID: 20530412
[TBL] [Abstract][Full Text] [Related]
18. The prognostic significance of the insulin-like growth factor-1 ligand and receptor expression in breast cancer tissue.
Chong KY; Subramanian A; Mokbel K; Sharma AK
J Surg Oncol; 2011 Sep; 104(3):228-35. PubMed ID: 21480260
[TBL] [Abstract][Full Text] [Related]
19. HTERT mRNA expression correlates with matrix metalloproteinase-1 and vascular endothelial growth factor expression in human breast cancer: a correlative study using RT-PCR.
Mansfield L; Subramanian A; Devalia H; Jiang W; Newbold RF; Mokbel K
Anticancer Res; 2007; 27(4B):2265-8. PubMed ID: 17695512
[TBL] [Abstract][Full Text] [Related]
20. Bcl-2 expression in breast cancer: a comparative study at the mRNA and protein level.
Martínez-Arribas F; Alvarez T; Del Val G; Martín-Garabato E; Núñez-Villar MJ; Lucas R; Sánchez J; Tejerina A; Schneider J
Anticancer Res; 2007; 27(1A):219-22. PubMed ID: 17352236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
